Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions, as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study

Elizabeth M. Ward; Ahmed Elshawadfy Sherif; Stephen O'Neill; Michael Hughes; Hamish Ireland; Stephen J. Wigmore; Anya Adair

doi:10.12659/AOT.931980

30 July 2021 : Original article

Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions, as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study

Elizabeth M. Ward^1ABCDEF, Ahmed Elshawadfy Sherif^12BCDEF*, Stephen O'Neill^3CD, Michael Hughes^1B, Hamish Ireland^4DE, Stephen J. Wigmore^1ADE, Anya Adair^1ADE

DOI: 10.12659/AOT.931980

Ann Transplant 2021; 26:e931980

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 3 The pattern of hepatocellular carcinoma recurrence in all patients after ablative therapies and surgical resection.

Variable	AT	SR	P value
			0.001^*
No recurrence	64 (69.6%)	40 (57.1%)
Local or resection margin recurrence	8 (8.7%)	6 (10.0%)
De-novo hepatic recurrence	19 (20.7%)	10 (14.3%)
Extra-hepatic recurrence	1 (1.1%)	13 (18.6%)
			0.056
Yes	20 (71.4%)	14 (46.7%)
No	8 (28.6%)	16 (53.3%)
^* Significant at 0.05 probability level.

Back to the Article

Clinical Outcomes of Ablation Compared with Resection for Single Hepatocellular Carcinoma Lesions, as a Primary Treatment or Bridging to Liver Transplantation: A Retrospective Comparative Study

Your Privacy